|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1993-9-10
|
|
pubmed:abstractText |
To compare the safety and immunogenicity of Lederle Laboratories' (Pearl River, NY) diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine with diphtheria and tetanus toxoids and whole-cell pertussis (DTwP) vaccine when administered simultaneously with measles-mumps-rubella (MMR) vaccine and trivalent oral poliovirus (OPV) vaccine at 15 to 16 months of age.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Bacterial,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Diphtheria-Tetanus-Pertussis Vaccine,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Measles Vaccine,
http://linkedlifedata.com/resource/pubmed/chemical/Measles-Mumps-Rubella Vaccine,
http://linkedlifedata.com/resource/pubmed/chemical/Mumps Vaccine,
http://linkedlifedata.com/resource/pubmed/chemical/Poliovirus Vaccine, Oral,
http://linkedlifedata.com/resource/pubmed/chemical/Rubella Vaccine
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0002-922X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
147
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
854-7
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8394646-Anorexia,
pubmed-meshheading:8394646-Antibodies, Bacterial,
pubmed-meshheading:8394646-Antibodies, Viral,
pubmed-meshheading:8394646-Bordetella pertussis,
pubmed-meshheading:8394646-Clostridium tetani,
pubmed-meshheading:8394646-Corynebacterium diphtheriae,
pubmed-meshheading:8394646-Diphtheria-Tetanus-Pertussis Vaccine,
pubmed-meshheading:8394646-Double-Blind Method,
pubmed-meshheading:8394646-Drug Combinations,
pubmed-meshheading:8394646-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:8394646-Erythema,
pubmed-meshheading:8394646-Female,
pubmed-meshheading:8394646-Fever,
pubmed-meshheading:8394646-Humans,
pubmed-meshheading:8394646-Infant,
pubmed-meshheading:8394646-Irritable Mood,
pubmed-meshheading:8394646-Male,
pubmed-meshheading:8394646-Measles Vaccine,
pubmed-meshheading:8394646-Measles virus,
pubmed-meshheading:8394646-Measles-Mumps-Rubella Vaccine,
pubmed-meshheading:8394646-Mumps Vaccine,
pubmed-meshheading:8394646-Mumps virus,
pubmed-meshheading:8394646-Poliovirus,
pubmed-meshheading:8394646-Poliovirus Vaccine, Oral,
pubmed-meshheading:8394646-Rubella Vaccine,
pubmed-meshheading:8394646-Rubella virus,
pubmed-meshheading:8394646-Sleep Stages
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Simultaneous administration of a diphtheria and tetanus toxoids and acellular pertussis vaccine with measles-mumps-rubella and oral poliovirus vaccines.
|
|
pubmed:affiliation |
Temple University School of Medicine, Philadelphia, Pa.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
